| [1] |
Giouleka S, Tsakiridis I, Mamopoulos A, et al. Fetal Growth Restriction: A Comprehensive Review of Major Guidelines[J]. Obstet Gynecol Surv, 2023, 78(11):690-708. doi: 10.1097/OGX.0000000000001203.
pmid: 38134339
|
| [2] |
毛冰昆, 吴雪, 姜亚倩, 等. 预测胎儿生长受限相关因子的研究进展[J]. 中国医药科学, 2022, 12(11):72-75. doi: 10.3969/j.issn.2095-0616.2022.11.019.
|
| [3] |
D'Agostin M, Di Sipio Morgia C, Vento G, et al. Long-term implications of fetal growth restriction[J]. World J Clin Cases, 2023, 11(13):2855-2863. doi: 10.12998/wjcc.v11.i13.2855.
pmid: 37215406
|
| [4] |
Sadiku E, Sun L, Macgowan CK, et al. Advanced magnetic resonance imaging in human placenta: insights into fetal growth restriction and congenital heart disease[J]. Front Cardiovasc Med, 2024, 11:1426593. doi: 10.3389/fcvm.2024.1426593.
|
| [5] |
Bitsadze V, Quarto A, Makatsarya A, et al. First-trimester placenta volume and three-dimensional vascularization[J]. Donald School J Ultrasound Obstet Gynecol, 2023, 17(3):270-276. doi: 10.5005/jp-journals-10009-1981.
|
| [6] |
Kalisch-Smith JI. Feto-placental blood vessel development[J]. Development, 2025, 152(11):dev204838. doi: 10.1242/dev.204838.
|
| [7] |
Nii M, Enomoto N, Ishida M, et al. Two-dimensional phase-contrast MRI reveals changes in uterine arterial blood flow in pregnant women administered tadalafil for fetal growth restriction[J]. Placenta, 2024, 146:1-8. doi: 10.1016/j.placenta.2023.12.013.
pmid: 38157651
|
| [8] |
Lee B, Janzen C, Aliabadi AR, et al. Early pregnancy imaging predicts ischemic placental disease[J]. Placenta, 2023, 140:90-99. doi: 10.1016/j.placenta.2023.07.297.
pmid: 37549442
|
| [9] |
Sun C, Groom KM, Oyston C, et al. The placenta in fetal growth restriction: What is going wrong?[J]. Placenta, 2020, 96:10-18. doi: 10.1016/j.placenta.2020.05.003.
pmid: 32421528
|
| [10] |
Trilla Solà C, Parra Roca J, Llurba Olivé E. Reference Ranges of 2-Dimensional Placental Biometry and 3-Dimensional Placental Volume between 11 and 14 Weeks of Gestation[J]. Diagnostics(Basel), 2024, 14(14):1556. doi: 10.3390/diagnostics14141556.
|
| [11] |
Gonzalez-Ortiz M. Advances in maternal-fetal biomedicine: cellular and molecular mechanisms of pregnancy pathologies[M]. Berlin: Springer International Publishing, 2023:1-29.
|
| [12] |
Guo Y, Huang C, Xu C, et al. Dysfunction of ZNF554 promotes ROS-induced apoptosis and autophagy in Fetal Growth Restriction via the p62-Keap1-Nrf2 pathway[J]. Placenta, 2023, 143:34-44. doi: 10.1016/j.placenta.2023.09.009.
pmid: 37804692
|
| [13] |
Vornic I, Nesiu A, Ardelean AM, et al. Antioxidant Defenses, Oxidative Stress Responses, and Apoptosis Modulation in Spontaneous Abortion: An Immunohistochemistry Analysis of First-Trimester Chorionic Villi[J]. Life(Basel), 2024, 14(9):1074. doi: 10.3390/life14091074.
|
| [14] |
Xie X, Liu J, Gao J, et al. The crosstalk between cell death and pregnancy related diseases: A narrative review[J]. Biomed Pharmacother, 2024, 176:116815. doi: 10.1016/j.biopha.2024.116815.
|
| [15] |
Kajdy A, Sys D, Modzelewski J, et al. Evidence of Placental Aging in Late SGA, Fetal Growth Restriction and Stillbirth-A Systematic Review[J]. Biomedicines, 2023, 11(7):1785. doi: 10.3390/biomedicines11071785.
|
| [16] |
Dos Anjos Cordeiro JM, Santos LC, Santos BR, et al. Manganese porphyrin-based treatment improves fetal-placental development and protects against oxidative damage and NLRP3 inflammasome activation in a rat maternal hypothyroidism model[J]. Redox Biol, 2024, 74:103238. doi: 10.1016/j.redox.2024.103238.
|
| [17] |
Joshi NP, Mane AR, Sahay AS, et al. Role of Placental Glucose Transporters in Determining Fetal Growth[J]. Reprod Sci, 2022, 29(10):2744-2759. doi: 10.1007/s43032-021-00699-9.
|
| [18] |
Huang B, Wang H, An Z, et al. Compromised Peroxisome Proliferator-Activated Receptor γ-Mediated Impaired Placental Glucose Transport Via the Phosphatidylinositol 3-Kinase/Protein Kinase B Signaling Pathway Is Associated With Fetal Growth Restriction[J]. Lab Invest, 2025, 105(4):104103. doi: 10.1016/j.labinv.2025.104103.
|
| [19] |
Xu Q, Wang J, Li Y, et al. The inhibition of placental mTOR signaling leads to fetal growth restriction with abnormal glucose metabolism in different anatomical regions of placentas[J]. Placenta, 2025, 164:31-40. doi: 10.1016/j.placenta.2025.03.008.
pmid: 40090159
|
| [20] |
Rosario FJ, Barentsen K, Powell TL, et al. Trophoblast-specific overexpression of the LAT1 increases transplacental transport of essential amino acids and fetal growth in mice[J]. PNAS Nexus, 2024, 3(6):pgae207. doi: 10.1093/pnasnexus/pgae207.
|
| [21] |
Hua Q, Li Z, Zhou Y, et al. Single-cell RNA sequencing reveals association of aberrant placental trophoblasts and FN1 reduction in late-onset fetal growth restriction[J]. Placenta, 2024, 146:30-41. doi: 10.1016/j.placenta.2023.12.022.
pmid: 38160601
|
| [22] |
Brouwers L, de Gier S, Vogelvang TE, et al. Prevalence of placental bed spiral artery pathology in preeclampsia and fetal growth restriction: A prospective cohort study[J]. Placenta, 2024, 156:1-9. doi: 10.1016/j.placenta.2024.08.010.
pmid: 39214009
|
| [23] |
Tan B, Lin L, Yuan Y, et al. Endothelial progenitor cells control remodeling of uterine spiral arteries for the establishment of utero-placental circulation[J]. Dev Cell, 2024, 59(14):1842-1859.e12. doi: 10.1016/j.devcel.2024.04.009.
pmid: 38663400
|
| [24] |
Tucci V, Isles AR, Kelsey G, et al. Genomic Imprinting and Physiological Processes in Mammals[J]. Cell, 2019, 176(5):952-965. doi: 10.1016/j.cell.2019.01.043.
pmid: 30794780
|
| [25] |
Liao L, Zhou X, Zhang M, et al. Epigenetic modification of IGF2/H19 imprinting control region regulates PGC-1α/PI3K/AKT2 pathway in a rat model of intrauterine growth restriction[J]. Chin Med J(Engl), 2024, 138(19):2472-2480. doi: 10.1097/CM9.0000000000003324.
|
| [26] |
Salmeri N, Carbone IF, Cavoretto PI, et al. Epigenetics Beyond Fetal Growth Restriction: A Comprehensive Overview[J]. Mol Diagn Ther, 2022, 26(6):607-626. doi: 10.1007/s40291-022-00611-4.
pmid: 36028645
|
| [27] |
Gong X, He W, Jin W, et al. Disruption of maternal vascular remodeling by a fetal endoretrovirus-derived gene in preeclampsia[J]. Genome Biol, 2024, 25(1):117. doi: 10.1186/s13059-024-03265-z.
pmid: 38715110
|
| [28] |
Deng F, Lei J, Qiu J, et al. DNA methylation landscape in pregnancy-induced hypertension: progress and challenges[J]. Reprod Biol Endocrinol, 2024, 22(1):77. doi: 10.1186/s12958-024-01248-0.
|
| [29] |
Norton C, Clarke D, Holmstrom J, et al. Altered Epigenetic Profiles in the Placenta of Preeclamptic and Intrauterine Growth Restriction Patients[J]. Cells, 2023, 12(8):1130. doi: 10.3390/cells12081130.
|
| [30] |
Selcen Cebe F, Nur Tola E, Aslan Koşar P, et al. DNA methylation profiles of genes associated with angiogenesis in the samples of placenta in pregnancies complicated by intrauterine growth restriction[J]. J Matern Fetal Neonatal Med, 2021, 34(17):2854-2862. doi: 10.1080/14767058.2019.1671344.
|
| [31] |
Liu L, Tang L, Chen S, et al. Decoding the molecular pathways governing trophoblast migration and placental development; a literature review[J]. Front Endocrinol(Lausanne), 2024, 15:1486608. doi: 10.3389/fendo.2024.1486608.
|
| [32] |
Wu JX, Shi M, Gong BM, et al. An miRNA-mRNA integrative analysis in human placentas and mice: role of the Smad2/miR-155-5p axis in the development of fetal growth restriction[J]. Front Bioeng Biotechnol, 2023, 11:1159805. doi: 10.3389/fbioe.2023.1159805.
|
| [33] |
Song W, Guo Q, Puttabyatappa M, et al. FGR-associated placental insufficiency and capillary angiogenesis involves disruptions in human placental miRNAs and mRNAs[J]. Heliyon, 2024, 10(6):e28007. doi: 10.1016/j.heliyon.2024.e28007.
|